News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
Gallery: The 10 best American cities for remote work
Seattle is the second-best city in America for remote work, according to a new ranking from CoworkingCafe. Rankings were determined by 11 metrics across categories
Seattle startup Optimize Health lands $18.6M to boost remote care software
Seattle-based Optimize Health completed its $18.6 million Series B funding round, which was led by Foundry and Escalate Capital Partners. The startup sells remote patient
Report: Shingles vaccine maker Curevo Vaccine signs lease in Bothell
Bothell-based biotech company, Curevo Vaccine, has a new home in the Seattle suburb. The shingles vaccine maker is leasing more than 13,600 square feet of
Life Science Washington Institute and Washington State Department of Commerce Award $500,000 to Life Science Startups
Life Science Washington Institute and the Washington State Department of Commerce awarded $500,000 in grants to organizations dedicated to creating innovative healthcare solutions. The grants
Avalyn Pharma raises $175M for pulmonary fibrosis treatments
Avalyn Pharma, a Seattle-based biopharma company, raised $175 million in a recent Series C funding round. Avalyn will use the funds to support development of
Cows burp out too much methane. This biotech startup is making a bovine Beano.
Seattle-based biotech company Lumen Bioscience is working to reduce atmospheric harm by reducing cows’ methane emissions. The company is developing a manufactured enzyme to prevent
Seagen’s cancer drug succeeds in ‘must-win’ trial
Bothell-based biotech company Seagen found success in a clinical trial testing a variety of cancer drugs. Roughly 1,000 participants joined the trial and some received
Lumen Bioscience wins historic $1.5M Wilkes Center Climate Prize
Lumen Bioscience, a Seattle-based biotech company, won the University of Utah’s $1.5 million Wilkes Center Climate Prize. 77 other candidates were submitted for the Wilkes
Bonum Therapeutics CEO named Top Industry Leader of 2023 by PharmaVoice 100
John Mulligan, CEO and founder of Seattle-based Bonum Therapeutics was named a Top Industry Leader in PharmaVoice 100’s 2023 Entrepreneurs ranking. PharmaVoice 100 celebrates the
Seattle biotech startup Deverra Therapeutics raising cash to develop cellular immunotherapies
Deverra Therapeutics, a biotech startup based in Seattle, has raised $2.4 million to support its immunotherapy platform, according to a recent SEC filing. With the
Otsuka and Shape Therapeutics: Revolutionizing Ocular Disease Treatments
Shape Therapeutics, a Seattle-based biotech company, announced a new partnership with pharmaceutical entity Otsuka. Their efforts will focus on creating new eye disease treatments with
Allen Institute hits 20 years on the frontier of bioscience, and Seattle will be all aglow
In honor of the Allen Institute’s 20th anniversary, Seattle and King County now recognize Sept. 16, 2023, as “Open Science Day.” The Allen Institute, founded